The QualityStocks Daily Tuesday, September 29th, 2020

Today's Top 3 Investment Newsletters

InvestorPlace (APM) +290.16%

QualityStocks (VPLM) +115.61%

MarketClub Analysis (ADIL) +114.89%

The QualityStocks Daily Stock List

Bionano Genomics, Inc. (BNGO)

NetworkNewsWire, Market Chameleon, MarketBeat, GlobeNewswire, last10k, Invest Million, Zacks, Proactive Investors, Investors Observer, News RTS, InvestorsHub, Street Insider, Market Screener, Wallet Investor, StocksRegister, Finbox, Nasdaq, YCharts, Investing.com, Finviz, PennyStocks, RTTNews, NewsDaemon, DBT News, GuruFocus, NasdaqNewsFeed, PR Newswire, Marketing Sentinel, Spotlight Growth, News Quantified, Fosters Research, Simply Wall St, iwatchmarkets, FX Street, Seeking Alpha, Morningstar, Invest Chronicle, Barchart, ChartMill, TMXmoney, MacroTrends, Stockhouse, Stocktwits, MarketWatch, and Investcom.com reported previously on Bionano Genomics, Inc. (BNGO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bionano Genomics, Inc. provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. A genome analysis company, its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection. The platform enables researchers and clinicians to hasten the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Founded in 2003, Bionano Genomics is headquartered in San Diego, California. Its shares trade on the NasdaqGS. The Company formerly known as BioNano Genomics, Inc. It changed its name to Bionano Genomics, Inc. in July of 2018.

The Saphyr system consists of an instrument, chip consumables, reagents, as well as a set of data analysis tools, and genome analysis services. This is to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs.

Saphyr detects all CNVs, chromosomal abnormalities, and structural variants. It consolidates the traditional cytogenetic assays into one single workflow. Saphyr can detect all structural variant types at high sensitivities. This includes those present at low allele fractions in heterogenous cancer samples, in an unbiased genome-wide way. This modern tool has revolutionized cytogenomics through showing a 100 percent concordance to traditional methods – array CGH, karyotyping, and also FISH.

Earlier this month, Bionano Genomics announced that teams from the Mayo Clinic and from the University of Florida have separately released results generated with Saphyr relating to Amyotrophic Lateral Sclerosis (ALS) and Myotonic Dystrophy (DM), respectively. These are two severe genetic disorders caused by the expansion of repetitive sequences in the genome.

Saphyr identified repeat expansions in patients with ALS and DM that were so large that only Saphyr is capable of sizing them correctly. The findings help increase understanding of the disease-causing mechanisms. The findings may lead to better diagnostic tests, support direct drug development, and facilitate better identification of patients who are likely to respond to treatment.

Last week, Bionano Genomics announced that MVZ Martinsried, a top clinical diagnostics service provider in Germany, received accreditation for use of Bionano’s digital cytogenetics platform, Saphyr, for laboratory developed tests (LDTs) as a vital element of their testing services moving forward. Approval was awarded by Deutsche Akkreditierungsstelle GmbH (DAkkS), the national accreditation body for the Federal Republic of Germany, following the one of the most stringent review processes in Europe.

Bionano Genomics, Inc. (BNGO), closed Tuesday's trading session at $0.5979, up 1.082%, on 6,154,413 volume with 7,490 trades. The average volume for the last 3 months is 22,506,601 and the stock's 52-week low/high is $0.25/$4.6999998.

Gold X Mining Corp. (GLDXF)

Global Banking and Finance, Crush the Street, Mining News Daily, Resource World, Mining Stock Education, Financial Content, Gold Stock Data, OTC Markets, InvestorX, Metals News, GlobeNewswire, Baystreet.ca, TMXmoney, InvestorsHub, Global Mining Review, Investing.com, MarketWatch, Market Screener, Morningstar, ValuetheMarkets, GuruFocus, Barchart, Stockhouse, Simply Wall St, YCharts, Seeking Alpha, TF Metals Report, TradingView, Tmx.com, and Mining Journal reported earlier on Gold X Mining Corp. (GLDXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gold X Mining Corp. is a junior mining company based in Centennial, Colorado. It is currently moving toward a Feasibility Study (FS) for the Toroparu Project in Guyana, South America with 7.4 million ounces of gold in the Measured and Indicated categories. The Company formerly went by the name Sandspring Resources Ltd. It changed its name to Gold X Mining Corp. in November of 2019. Incorporated in 2006, Gold X Mining lists on the OTC Markets Group’s OTCQX.

Additionally, the Company holds a 100 percent interest in the Chicharrón Project located in the Segovia-Remedios mining district, Antioquia, Colombia. Concerning the Toroparu Gold Deposit, it is in the highly prospective Upper Puruni River Region of western Guyana. It contains the largest in-situ gold projects owned by an independent junior mining company in South America.

Gold X Mining’s 100 percent controlled Upper Puruni Concession contains 53,844 hectare (538 km2) of mineral leases situated in the Cuyuni-Mazaruni Region (Region 7) of Western Guyana. Facilities at Toroparu include a 200-person camp and 2,500-foot all-weather airfield.

The Company has spent greater than US$150 million on the Toroparu Project to date to both classify 7.35 million ounces of Measured and Indicated and 3.15 M-oz of Inferred Gold Resources, develop engineering studies for use in a Feasibility Study (FS), and define several exploration targets around Toroparu on its 100 percent owned Upper Puruni Concession.

A Preliminary Economic Assessment (PEA) study (Preliminary Economic Assessment Report, Toroparu Gold Project, Upper Puruni River Area, Guyana, dated July 18, 2019 completed by SRK Consulting (U.S.), Inc.) defined a 5.02 M-oz Potentially Mineable Gold Resource producing 188,000 ounces of gold per year over a 24-year mine-life.

At present, Toroparu is accessed overland via the 240-km Itiballi-Puruni-Papishao Landing Road, which Gold X Mining rehabilitated in 2003, and is a major corridor for western Guyana and one of its important gold producing areas. Plans include completion of a second access road extending to the north to Buckhall on the Essequibo River.

This month, Gold X Mining reported that, further to its Press Release of September 8, 2020, all of the remaining 710,832 warrants with an exercise price of $2.40 that expired September 11, 2020 and all of the remaining 639,473 warrants with an exercise price of $1.30 set to expire on September 24, 2020 were exercised. Proceeds from both exercises were $2,537,312.

The Company currently has 52,734,877 million common shares issued and outstanding and 77,053,153 on a fully diluted basis. Following the exercise of these warrants, Gold X Mining has $13.2 million to fund its activities.

Gold X Mining Corp. (GLDXF), closed Tuesday's trading session at $2.79, off by 0.711744%, on 65,836 volume with 82 trades. The average volume for the last 3 months is 46,068 and the stock's 52-week low/high is $0.579999983/$3.50600004.

Liquidia Technologies, Inc. (LQDA)

Stocktwits, Zacks, GlobeNewswire, Stock News, Nasdaq, Webull, Simply Wall St, Morningstar, Fintel, MarketWatch, Investing.com, Stockhouse, last10k, ETF.com, TipRanks, MacroTrends, Market Chameleon, Market Screener, Invest Million, GuruFocus, Barchart, YCharts, Investors Observer, Finviz, Seeking Alpha, and MarketBeat reported beforehand on Liquidia Technologies, Inc. (LQDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company listed on the NasdaqGS. It focuses on the development and commercialization of novel products utilizing its proprietary PRINT® technology. The Company’s method for precisely engineering drug particles to new specification can enhance the therapeutic potential of the molecule for the patient. This is while minimizing risk and lessening time to market. Established in 2004, Liquidia Technologies has its corporate headquarters in Morrisville, North Carolina.

PRINT® technology gives the pharmaceutical industry the power to produce precise drug particles, clinically-effective products at scale, and in some cases decrease manufacturing complexity and cost. Liquidia Technologies’ proprietary PRINT technology brings the pharmaceutical industry the ability to design drug particles uniformly and in a broad array of compositions, sizes, and shapes.

PRINT technology integrates proprietary particle engineering technology with a modular, roll-to-roll manufacturing process to create precisely-constructed molds in which particle chemistry can take place. Liquidia Technologies is applying PRINT technology toward internal product development opportunities.

The pipeline strategy is centered on improving presently approved products so as to minimize development risk and increase speed to market. Current product candidates in clinical development encompass LIQ861 for pulmonary arterial hypertension (PAH) and LIQ865 for local, post-operative pain.

Recently, Liquidia Technologies announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application No. 16/099,135 related to LIQ861, Liquidia’s proprietary dry powder treprostinil now under review with the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH). The patent is expected to cover methods of treating patients with pulmonary hypertension via the inhalation of dry powder treprostinil. The patent, expected to be issued in Q4 of 2020, should have a term that expires no earlier than 2037.

On September 17, 2020, Liquidia Technologies announced that the special meeting of its stockholders to vote on the proposed acquisition of RareGen, LLC pursuant to the Agreement and Plan of Merger, dated June 29, 2020, will take place on October 21, 2020, at 4:30 p.m., Eastern Time. On September 16, 2020, Liquidia Corporation’s Registration Statement on Form S-4 relating to the proposed acquisition was declared effective by the U.S. Securities and Exchange Commission (SEC).

Mr. Neal Fowler, Chief Executive Officer of Liquidia Technologies, said, “We remain on track for the close of the RareGen acquisition and today marks another step toward completing this transformational transaction for our company, which we believe represents value for our stockholders and patients with pulmonary arterial hypertension. We are encouraged by the ongoing support we are receiving from our employees and stockholders, as well as the significant progress we have made on integration planning, which continues to be our focus.”

Liquidia Technologies, Inc. (LQDA), closed Tuesday's trading session at $4.90, up 3.1579%, on 164,800 volume with 1,529 trades. The average volume for the last 3 months is 377,901 and the stock's 52-week low/high is $2.65000009/$12.1000003.

Luna Innovations Incorporated (LUNA)

Investor Village, Zacks, Rocket Reach, Business Wire, Finviz, MacroTrends, Proactive Investors, Annual Reports, Invest Million, Nasdaq, Seeking Alpha, InvestorsHub, GlobeNewswire, Directors Talk Interviews, Simply Wall St, last10k, Morningstar, YCharts, Stocktwits, Stockhouse, TMXmoney, Parabolic Arc, and Composites World reported previously on Luna Innovations Incorporated (LUNA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Luna Innovations Incorporated is a leader in optical technology. The Company is organized into two business segments. One is a Technology Development segment and the other is a Products and Licensing segment. The design of Luna’s business model is to hasten the process of bringing new and inventive technologies to market. Founded in 1990, Luna Innovations is based in Roanoke, Virginia. The Company lists on the NasdaqGS.

Fundamentally, Luna Innovations develops and manufactures new-generation products for the healthcare, telecommunications, energy, as well as defense markets. Its products are used to measure, monitor, protect, and improve critical processes in the markets it serves.

Luna Innovations provides unique capabilities in high-performance, fiber optic-based, test products for the telecommunications industry and distributed fiber optic-based sensing for the aerospace and automotive industries. The Company’s business consists of Fiber Optic Sensing; Fiber Optic Test & Measurement; TeraMetrix – Terahertz Solutions; and Luna Labs- Applied Research & Development.

Last month, Luna Innovations announced that it has partnered with CETENA and GHT Photonics to help design, build, and implement a full-scale, fiber-optic structural health monitoring system for the recently re-opened Polcevera Viaduct bridge, which is a vital traffic artery for the City of Genoa in northern Italy. The unique bridge is more than a kilometer long. It features 19 spans. It is equipped with an advanced health monitoring system based on a network of Luna’s HYPERION® measurement systems and advanced fiber optic sensors installed by Luna’s integration partner GHT photonics.

Earlier this month, Luna Innovations shared that its corrosion monitoring products were chosen by Lockheed Martin to monitor critical environments on board NASA’s Orion spacecraft. Part of the Artemis program, Orion is the only spacecraft precisely developed for crewed missions into deep space, supporting NASA’s mission to build a sustainable presence on the lunar surface and on to Mars.

Luna Innovations’ products are helping to attain spacecraft reusability. This is an important cost saver for sustainable exploration of the Moon and deep space. NASA plans to reuse flown Orion crew modules. Luna’s products will report valuable information used to measure integrity of the module throughout the mission and for reuse determination.

Within the interior of the crew module, the Company’s products will monitor environmental stability as crews exercise, use the waste management system, and access potable water throughout spaceflight. On the exterior of the module, Luna’s products will record corrosive conditions as the capsule returns to Earth, splashes down into the ocean, and is transported back to NASA’s Kennedy Space Center in Florida.

Luna Innovations Incorporated (LUNA), closed Tuesday's trading session at $5.98, up 0.33557%, on 84,497 volume with 1,103 trades. The average volume for the last 3 months is 237,990 and the stock's 52-week low/high is $4.50/$9.31999969.

On Track Innovations Ltd. (OTIVF)

Market Screener, OTC Markets, Zacks, Webull, Value Forum, last10k, Wallet Investor, Infront Analytics, Morningstar, Investing.com, Stockhouse, YCharts, GuruFocus, Nasdaq, PR Newswire, Barchart, Dividend Investor, Canadian Insider, Insider Tracking, Seeking Alpha, docoh, and Whale Wisdom reported earlier on On Track Innovations Ltd. (OTIVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

On Track Innovations Ltd. is a global provider of near field communication (NFC) and cashless payment solutions. The OTCQX-listed Company is a pioneer and leading developer in inventive FinTech, including near field communication. It engages in the design, manufacture, and sale of secure cashless payment solutions using contactless NFC technology. It distributes and supports its solutions through a worldwide network of regional offices and alliances. Founded in 1990, On Track Innovations is headquartered in Rosh Pina, Israel.

The Company’s field-proven innovations have been deployed around the world to address cashless payment, automated retail, as well as petroleum markets. On Track Innovations’ vision is to make a cashless payment society a reality. Its emphasis is cashless payment with telemetry management solutions for automated retail, self-service kiosk, micro-markets, unattended vending, EV charge points, coin-op pulse, mobile and IoT (Internet of Things) wearables and more.

On Track Innovations has a field-proven series of cashless payment solutions based on an extensive IP (Intellectual Property) portfolio. This includes registered and patented applications internationally. The Company has four major regional offices with deployment in 55 countries worldwide.

In August, On Track Innovations announced financial results for Q2 ended June 30, 2020. Revenue in the quarter increased by 18 percent to $4.9 million, versus $4.1 million in Q2 of 2019. Recurring Revenues were $0.9 million, versus $1.2 million in Q2 of last year.

Net Loss was $1.1 million, versus a Net Loss of $0.9 million in the same year-ago quarter. As of June 30, 2020, On Track Innovations had Cash and Cash Equivalents and Short-Term Investments of $5.2 million.

Mr. Yehuda Holtzman, On Track Innovations’ Chief Executive Officer, said last month, "We reported second quarter revenues of $4.9 million, representing growth of 18% compared to the second quarter of 2019. The total revenues in the first half of 2020 were just over $9.3 million, a growth of 31% compared to the same period a year ago. This growth was despite the rising impact of the COVID-19 pandemic on the business environment, which mainly affected our Mass Transit Ticketing sales in the Polish Market and has lengthened the sales cycle for our payment business.”

On Track Innovations Ltd. (OTIVF), closed Tuesday's trading session at $0.4315, up 14.7606%, on 45,806 volume with 15 trades. The average volume for the last 3 months is 70,487 and the stock's 52-week low/high is $0.119999997/$0.689999997.

RealNetworks, Inc. (RNWK)

Stocktwits, Zacks, Investors Observer, Stockhouse, PR Newswire, Wallet Investor, Market Screener, Morningstar, MacroTrends, AI Stock Finder, ETF.com, Equities.com, Invest Million, Nasdaq, Seeking Alpha, Morningstar, YCharts, Simply Wall Street, last10k, GuruFocus, TMXmoney, Dividend Investor, DBT News, MZP News, MarketBeat, EarningsCast, Finviz, MarketWatch, and Stocknews reported earlier on RealNetworks, Inc. (RNWK), and we today we report on the Company, here at the QualityStocks Daily Newsletter.

RealNetworks, Inc. has a legacy of digital media expertise and innovation. It has created a new generation of products that use best-in-class artificial intelligence (AI) and machine learning to enhance and secure daily lives. The Company provides network-delivered digital media applications and services to manage, play, and share digital media. NasdaqGS-listed, RealNetworks is headquartered in Seattle, Washington.

The Company’s products include SAFR and Kontxt. SAFR is the globe’s premier facial recognition platform for live video. SAFR leads in real world performance and accuracy as evidenced in testing by NIST. SAFR enables new applications for security, convenience, and analytics. SAFR can be deployed on premises, in the cloud, or with a VMS.

Kontxt is the top platform for categorizing A2P messages to help mobile carriers build customer loyalty and increase new revenue through text message classification and antispam. One can take a stream of messages and let Kontxt™ analyze and classify them. As a result, one can deliver the right messages to the right recipients, at the right price, and with the right service characteristics.

In addition, a user gets next-generation spam and gray route detection. RealNetworks’ other product offerings include RealMedia® HD, Mobile Carrier Services, GameHouse, RealPlayer, and RealTimes.

SAFR from RealNetworks now has its SAFR® Inside. This is a new app component of its Facial Recognition and Computer Vision Platform that runs on ACAP enabled cameras with edge processing capabilities. SAFR Inside reduces network traffic and server overhead and thus lessens overall deployment costs.

Last month, SAFR® from RealNetworks announced it was awarded two Phase II Small Business Innovation Research (SBIR) contracts of about $950k each or $1.9M in total from AFWERX. The contracts provide funding to adapt the SAFR platform for use by the Air Force for perimeter security and secure access. Once developed for the USAF, the SBIR/STTR program allows for any other federal agency to award a sole-source contract for technology developed under the program.

Additionally, in August, RealNetworks announced its support for the acquisition of Rhapsody International, Inc., which does business as Napster, by MelodyVR Group PLC. RealNetworks is the majority owner of Napster, with a roughly 84 percent stake. MelodyVR Group PLC is the foremost creator of live virtual reality music experiences. Its intention is to combine its MelodyVR subsidiary with Napster to create a new differentiated entity. The expectation is that this acquisition will close in Q4 of 2020.

RealNetworks, Inc. (RNWK), closed Tuesday's trading session at $1.21, off by 1.626%, on 55,990 volume with 271 trades. The average volume for the last 3 months is 752,157 and the stock's 52-week low/high is $0.319999992/$2.24.

SLANG Worldwide, Inc. (SLGWF)

Midas Letter, MarketWatch, Marijuana Stocks Report, NIC Investors, New Cannabis Ventures, MarketBeat, WeedStreet420, Ask Finny, Seeking Alpha, Stockhouse, Investors Observer, Barchart, Trade Ideas, GuruFocus, OTC.Watch, OTC Markets, Wallet Investor, Smarter Analyst, Equities.com, Nasdaq, TipRanks, Market Screener, Insider Financial, Dividend.com, Macroaxis, Newfilecorp, TradingView, Stock Target Advisor, Morningstar, and Fintel reported earlier on SLANG Worldwide, Inc. (SLGWF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SLANG Worldwide, Inc. is a foremost international cannabis consumer packaged goods (CPG) enterprise with a diverse portfolio of popular brands distributed throughout the United States. It specializes in acquiring and developing market-proven regional brands and also launching unique new brands to seize worldwide market opportunities. The OTCQB-listed Company previously went by the name Fire Cannabis, Inc. It changed its corporate name to SLANG Worldwide, Inc. in November 2018. Incorporated in 2017, SLANG Worldwide is based in Toronto, Ontario.

The Company has a strong portfolio of renowned brands distributed across greater than 2,600 stores in 12 U.S. States. The SLANG Network is a combination of licensed cannabis manufacturers, distributors, as well as ecommerce distribution platforms that sell its branded products.

SLANG Worldwide mainly generates revenues from collecting licensing fees and selling certain product components including flavoring concentrates/bases, packaging, and hardware pieces. It also generates revenue selling certain non-plant touching products, such as its Firefly vaporizer. The Company continues to expand its presence in established and developing cannabis markets globally.

SLANG’s network operates via multiple local channels. The chief way that its products reach the marketplace begins with SLANG, which manufactures and sells product formulation bases and packaging to SLANG Network operations. SLANG does not own or control all of its network partners.

Earlier in September, SLANG Worldwide announced that it acquired the licensed cannabis producer and distributor, Peoria Partners LLC. Peoria is the State-licensed manufacturer and distributor of SLANG's District Edibles brand in Colorado. SLANG’s intention is to continue to use Peoria's Denver facilities for the manufacture of District Edibles and for the distribution of the full set of SLANG-branded products within Colorado.

Moreover, this month, SLANG Worldwide announced a strategic partnership with Trulieve Cannabis Corp. (CSE: TRUL) & (OTCQX: TCNNF), a foremost and top-performing cannabis company headquartered in the USA, to introduce SLANG-branded products to consumers in Massachusetts. With this partnership, Trulieve has been granted an exclusive license to produce and distribute the SLANG product family in Massachusetts. This includes its category-leading brands O.penVAPE, Firefly, Pressies, District Edibles, and Bakked. SLANG will provide sales consulting services and will receive royalty payments for each branded product sold in Massachusetts.

Today, SLANG Worldwide announced that it entered into an agreement dated September 25, 2020 to acquire Colorado-licensed cannabis cultivator Pleasant Valley Ranch, LLC. SLANG anticipates that ownership of a cultivation operation will provide more assurance of a supply of raw materials in the growing Colorado market, while also lessening its input costs and therefore improving gross margins. Pleasant Valley specializes in high-quality, organically grown cannabis strains, which thrive in high altitude, mountainous environments.

SLANG Worldwide, Inc. (SLGWF), closed Tuesday's trading session at $0.0933, up 3.208%, on 109,612 volume with 24 trades. The average volume for the last 3 months is 260,601 and the stock's 52-week low/high is $0.075000002/$0.479999989.

Future Farm Technologies, Inc. (FFRMF)

Infront Analytics, Zacks, MarketWatch, Investing Daily, Seeking Alpha, Stockhouse, Stockwatch, Dividend.com, Daily Marijuana Observer, OTC Markets, Barchart, TMXmoney, Morningstar, GuruFocus, OTC.Watch, Proactive Investors, Investors Hangout, Dividend Investor, TradingView, Marijuana Stocks, TipRanks, MarketBeat, GlobeNewswire, InvestorX, CannabisFN, Macroaxis, Nasdaq, Wallet Investor, BioSpace, NIC Investors, and InvestorsHub reported earlier on Future Farm Technologies, Inc. (FFRMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Future Farm Technologies, Inc. is positioned to be a foremost supplier of hemp-derived CBD (cannabidiol) products to meet the increasing demand in the U.S. and worldwide markets. Its experienced management team has a deep understanding of operations and agriculture with the financial and regulatory expertise required to become an industry leader in the changing market for CBD and related compounds. The OTCQB-listed Company previously went by the name Arcturus Growthstar Technologies, Inc. It changed its corporate name to Future Farm Technologies, Inc. in February of 2017. Future Farm Technologies has offices in Vancouver, British Columbia, and Dedham, Massachusetts.

Future Farm current important initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities across the USA, and the development of elite strains of cannabis in Canada. Future Farm Technologies announced in October of 2019 that hemp from its farm in Hersey, Maine passed the State-mandated testing for acceptable (i.e. below 0.3 percent) levels of THC (Tetrahydrocannabinol). The Company harvested its hemp in October and completed the drying and curing phase of the biomass for extraction and seeds. Both crops achieved yields that outpaced the Company’s apparatus for seed extraction, plant bucking, processing, and also storage.

Future Farm Technologies continues to pursue licenses to grow cannabis for sale, research and development in Canada. It has discontinued projects related to marijuana in the United States to enhance its access to capital and simplify other aspects of business operations. This includes banking and tax planning. It owns a completely operational greenhouse business on about 10-acres in Apopka, Florida known as White Sand Nursery. Currently, White Sand grows ornamental plants that sell in large retail stores throughout North America. In response to the recent passage of the 2018 U.S. Farm Bill, Future Farm decided to expand its existing hemp portfolio to include a partnership in Florida.

The heart of Future Farm Technologies’ breeding and genetics operation are in its relationship with CEPG Consulting and Design, Inc. (CEPG). CEPG is an experienced developer of controlled environment plant growth systems located in St. John’s, Newfoundland.

Recently, Future Farm Technologies and High Purity Natural Products, LLC announced that on May 27, 2020, the parties signed a Letter of Intent (LOI) to merge. Subsequently, on July 7, 2020, Future Farm Technologies announced it completed the merger with High Purity Natural Products of Southbridge, Massachusetts, a US leader in advanced contract manufacturing of natural health and wellness products featuring CBD and hand-sanitizer products. Future Farm Technologies was already providing strategic and financial resources to support the quick growth of High Purity’s business. That business includes High Purity’s established operations as a leader in advanced contract manufacturing of health and wellness products featuring CBD and its recent expansion into the hand sanitizer product lines that retailers and other business customers are requiring because of the COVID-19 pandemic.

Future Farm Technologies, Inc. (FFRMF), closed Tuesday's trading session at $0.023, up 43.75%, on 145,584 volume with 36 trades. The average volume for the last 3 months is 167,134 and the stock's 52-week low/high is $0.011599999/$0.059999998.

Rapid Nutrition Plc. (RPNRF)

Spotlight Growth, OTC.Watch, PR Newswire, Market Screener, Wallet Investor, OTC Markets, Nasdaq, Small Cap Voice, Stockaholics, InvestorsHub, Penny Stock Hub, Barchart, YCharts, Dividend Investor, GlobeNewswire, PharmiWeb, PennyStocks.news, Business Insider, GuruFocus, New Media Wire, Financial Buzz, Seeking Alpha, Central Charts, and TradingView reported earlier on Rapid Nutrition Plc. (RPNRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rapid Nutrition Plc. is a natural healthcare company based in London, United Kingdom. It focuses on the research, development, and production of a range of life science products. In 2001, Mr. Simon St Ledger (a personal trainer and dietary consultant), and the Chief Executive Officer, founded Rapid Nutrition in Australia. The Company’s core business is the creation of organic and natural scientific-based health food supplements and building them into recognized brands. Rapid Nutrition lists on the OTC Markets’ OTCQB.

Rapid Nutrition was formed based on its successful and proven weight loss supplement range. This is exported globally. The Company now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns. In addition, it provides a number of wider services to the life sciences industry. Rapid Nutrition has registered products in and/or exported its products to Australia, Asia, Europe, the Middle East, Africa, and the United States.

Rapid Nutrition entered into a joint venture (JV) agreement with Motivate Health Technology, Inc. in 2012 to distribute System LS™ products directly to U.S. customers. In 2013, the Company won the Australian government export awards and was recognized as national finalist in the biotechnology sector.

Rapid Nutrition had expanded distribution into markets in Asia, Europe, Africa, and the Middle East by 2014. In 2015, the Company successfully formulated and launched the System LS™ in Australia and the United States. Over 2016 and 2017, Rapid Nutrition started and completed the development of a range of certified vegan protein formulas. The vegan certified protein powder adds an additional product extension to its current flagship brand System LS™. Rapid Nutrition secured the Exclusive Master Distribution rights for Australia with General Nutrition Corporation (GNC) in 2018.

Recently, Rapid Nutrition announced it will launch a new oral anti-viral treatment called Azurene designed to combat influenza and the common cold in humans. Rapid Nutrition is in discussions with the Australian government and top universities to conduct further testing. Independent testing at two laboratories has already confirmed the product's strong antiviral activity and a provisional patent application has been filed.

Azurene is the product of years of research based on in-vitro testing, scholarly literature and continuing clinical trials ahead of product launch. The expectation is that the anti-viral and anti-inflammatory formula will be safe for use among all ages, including children and seniors.

Rapid Nutrition Plc. (RPNRF), closed Tuesday's trading session at $0.1949, up 77.0209%, on 500 volume with 1 trade. The average volume for the last 3 months is 9,347 and the stock's 52-week low/high is $0.079999998/$0.349999994.

Lift & Co. Corp. (LFCOF)

OTC Markets, Stock Day Media, Technical420, Morningstar, Nasdaq, InvestorsHub, Investor Ideas, Stockwatch, TipRanks, Newsfilecorp, Market Screener, TradingView, Investing.com, Barchart, Stockhouse, Seeking Alpha and GlobeNewswire reported beforehand on Lift & Co. Corp. (LFCOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Lift & Co. Corp. is a technology enterprise modernizing the cannabis industry. It is vertically integrated across the cannabis value chain with a differentiated and succeeding strategy. The Company monetizes a platform of advertising solutions, events, and data insights to cannabis businesses and consumers for making better-informed decisions. Lift & Co. has its corporate headquarters in Toronto, Ontario.

Lift & Co. monetized greater than 80 percent of selling licensed producers (LPs) in the last 12 months. The Company has realized 248 percent growth in annual trailing twelve month (ttm) revenues as of December 2018. Lift & Co. Tradeshows host 20,000-plus attendees and were the first platform channel. Moreover, the Company provides non-restricted product and brand information by way of product reviews. This creates an opportunity for B2C (Business to Consumer) marketing.

Lift & Co. looks to aggregate and connect the three most valuable stakeholders in the value chain. These are Consumers, Licensed Producers (LPs), as well as Licensed Retailers. Lift & Co. is an ecosystem of cannabis marketing and analytics platforms. These create unique competitive advantages for brands and retailers to capture consumers, budtenders and data insights.

Recently, Indiva Limited (NDVA.V) (NDVAF) and Lift & Co. announced the release of Indiva’s CannSell branded education module. The CannSell certification program, created by Lift & Co., in exclusive partnership with MADD Canada, is presently used in eight Canadian jurisdictions.

In addition, CannSell serves as the provincially-mandated training program for all cannabis retail workers in the Province of Ontario. These frontline staff members are responsible for educating consumers on the safe use of cannabis where it is sold. The Indiva education experience on the CannSell platform offers an overview of the Company, its product portfolio, as well as its dedication to quality, innovation and sustainability.

Recently, Lift & Co. announced a strategic partnership with MCI USA, a recognized leader in meetings, events, and conferences, to grow Lift & Co.’s events portfolio. Also, the Company announced that in response to the present COVID-19 pandemic, it has successfully rescheduled its flagship Lift & Co. Expo in Toronto, Ontario to November 22-25, 2020 at the Metro Toronto Convention Centre (Toronto Expo 2020).

MCI USA is part of MCI Group, a global leader in event management. Lift & Co. chose MCI USA as a strategic growth partner based on the company’s record of scaling event portfolios and their prior investment in the North America cannabis industry via a strategic event partnership with the National Cannabis Industry Association (NCIA).

Lift & Co. Corp. (LFCOF), closed Tuesday's trading session at $0.01105, up 41.6667%, on 10,001 volume with 2 trades. The average volume for the last 3 months is 20,485 and the stock's 52-week low/high is $0.0051/$0.121399998.

Cyber Security 1 AB (CYBNY)

Stockhouse, GlobeNewswire, Seeking Alpha, TradingView, Morningstar, TeleTrader, Dividend Investor, 4-Traders, YCharts, and GuruFocus reported earlier on Cyber Security 1 AB (CYBNY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cyber Security 1 AB is an international leader in Cyber Security. The Company provides cyber resilience solutions and conducts its operations through physical presences in Sweden, South Africa, the United Kingdom (UK), Kenya, Germany, Austria, Turkey, Greece, Italy, the Ukraine and the United Arab Emirates (UAE). The Company formerly went by the name Cognosec AB (publ). It changed its name to Cyber Security 1 AB in July of 2018. Cyber Security 1 AB is based in Stockholm, Sweden. The Company lists on the OTC Markets Group’s OTCQX.

Providing governance, risk, and compliance cybersecurity solutions, Cyber Security 1 provides solutions for client and information systems audit, penetration testing, application security assessment, and security monitoring. In addition, the Company provides solutions for urgent incident response and crisis management, data leakage and loss prevention, and network security and management.

Cyber Security 1 has a growing international footprint, an impressive client list, a flourishing mergers and acquisition (M&A) strategy and in 2019 a newly appointed Chief Executive Officer (CEO). Furthermore, Cyber Security 1 had revenues of 44.54m EUR in 2018 and employed 239 personnel at the end of Q4 2018.

Cyber Security 1 announced earlier this year an exclusive five-year partnership with Formula 1®, the world’s premier motorsport series. It will provide Formula 1® with an assortment of resilient solutions, designed to enhance and secure Formula 1’s infrastructure from potential cyber threats. Cyber Security 1 will work closely with the Information Technology (IT) department at Formula 1®, delivering a number of key projects. This includes consultancy, implementation, and advisory.

Cyber Security 1 announced this past March the signing of exclusive Heads of Terms of Agreement pursuant to the acquisition of IntaForensics. Since IntaForensics’ formation in 2006, the business has grown worldwide to provide the widest variety of Digital Forensic and Cyber Security Services from its England headquarters.

IntaForensics is one of the fastest growing Digital Forensic Services providers globally. It is one of a few organizations that possesses the prestigious ISO/IEC 17025 Laboratory Standard. Additionally, it is accredited to ISO/IEC 27001 and ISO 9001. The business is accredited by the PCI Security Standards Council as a Qualified Security Assessor and a PCI Forensics Investigator (QSA, PFI).

Cyber Security 1 AB (CYBNY), closed Tuesday's trading session at $1.00, up 143.9024%, on 602 volume with 3 trades. The average volume for the last 3 months is 850 and the stock's 52-week low/high is $0.100000001/$5.00.

GlyEco, Inc. (GLYE)

Stockpools, Zacks, Stockwatch, Alternative Energy Stocks, GuruFocus, The Street, MarketWatch, Simply Wall St, Stockhouse, Equity Clock, Market Screener, Barchart, Equities, Real Investment Advice, Last10k, Wallet Investor, Accesswire, Seeking Alpha, Marketbeat, Dividend Investor, and InvestorsHub reported earlier on GlyEco, Inc. (GLYE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A chemical company, GlyEco, Inc. focuses on technology development and the manufacturing of coolants, additives, as well as related performance fluids. The Company specializes in coolants, additives, and related performance fluids, which protect equipment that needs to work hard. This includes on-road engines, and stationary engines to fluid containing systems and other equipment that uses glycol-based fluids. GlyEco has its corporate office in Institute, West Virginia. The Company lists on the OTC Markets.

GlyEco serves and supports the automotive, heavy-duty, and industrial markets and its speciality is chemical manufacturing. GlyEco’s Institute, West Virginia distillation facility produces antifreeze grade and industrial grade mono-ethylene glycol.

GlyEco acquired WEBA Technology Corp. in December of 2016. Since 2002, WEBA has been producing inhibitors for water/glycol solutions. WEBA manufactures METALGUARD additives. These are concentrated inhibitor packages to protect numerous metal types in diverse applications.

WEBA Technology product lines include METALGUARD Extended life additives (OAT, HOAT, NOAT, P-OAT, S-OAT); METALGUARD Conventional additives (light and heavy-duty); METALGUARD Heat transfer fluid additives; and Specialty and Custom inhibitors.

GlyEco offers an array of antifreeze products. These include Light-Duty Extended Life; Universal Extended Life Antifreeze; Poly-Organic Extended Life Antifreeze; Heavy-Duty Conventional Antifreeze; and OAT Heavy-Duty Extended Life Antifreeze.

Recently, GlyEco announced financial results for the full year ended December 31, 2018. The Company completed the sale of its assets related to its consumer segment effective January 11, 2019. Full Year 2018 highlights include Net Revenues of $6.5 million. This is up 11 percent versus $5.8 million for Full-Year 2017.

Total Gross Profit was $1,285,000, or 20 percent of Revenues, versus $885,000, or 15 percent of Revenues for 2017. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a non-GAAP measure, was $(1,565,000) versus $(2,331,000) for 2017. GlyEco reported a Net Loss of $3,452,000 for 2018, versus a Net Loss of $5,078,000 for 2017.

GlyEco, Inc. (GLYE), closed Tuesday's trading session at $0.20, up 566.6667%, on 400 volume with 1 trade. The average volume for the last 3 months is 107 and the stock's 52-week low/high is $0.029999999/$1.00.

CurAegis Technologies, Inc. (CRGS)

Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division.  CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.

The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.  Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.

In December, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015. He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.

CurAegis Technologies, Inc. (CRGS), closed Tuesday's trading session at $0.06125, up 43.7793%, on 20,090 volume with 3 trades. The average volume for the last 3 months is 42,364 and the stock's 52-week low/high is $0.005599999/$0.150000005.

Voip-Pal.com, Inc. (VPLM)

SmallCapVoice, SmallCapAllStars, FeedBlitz, TheSUBWAY, Stock Twiter, Pumps and Dumps, Equities, VC Stock Marketing, Clutch Investments, Equities Canada, TryBestPennyStocks, Buzz Stocks, and UndiscoveredEquities reported on Voip-Pal.com, Inc. (VPLM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Voip-Pal.com, Inc. owns a portfolio of patents relating to Voice-over-Internet Protocol (VoIP) technology. The OTCQB-listed Company is now looking to monetize its fundamental patents by way of a sale or licensure of its technology. In December 1997, Voip-Pal.com incorporated in the State of Nevada. In 2013, it acquired Digifonica International (DIL) Limited to fund, co-develop, and complete Digifonica's patent collection. Voip-Pal.com has its corporate office in Bellevue, Washington.

Voip-Pal’s Intellectual Property (IP) value comes from manifold issued US Patent and Trademark Office (USPTO) patents. This includes five parent patents, one of which is foundational and the others that build upon the former. The five core patents are: Routing, Billing & Rating (RBR);  Lawful Intercept; Enhanced E-911; Mobile Gateway; and Uninterrupted Transmission.

Voip-Pal.com’s patented technology provides Universal numbering ubiquity; network value as defined by Metcalfe; the imperative of interconnect, termination, and recompense for delivery of calls by other networks; and regulatory compliance in regulated markets. Additionally, the Company’s patented technology provides interconnection of VoIP networks to mobile and fixed networks; and maintenance of uninterrupted VoIP calls across fixed, mobile, and Wi-Fi networks.

Voip-Pal believes that its Lawful Intercept patents could prove to be a vital tool for law enforcement in its efforts to combat crime and stop terror attacks. The technology provides the means for judicially authorized covert intercept of any kind of communications sent through VoIP. This includes voice calls, media, as well as messaging.

Voip-Pal.com, Inc. (VPLM), closed Tuesday's trading session at $0.029, up 115.6134%, on 29,994,619 volume with 1,315 trades. The average volume for the last 3 months is 1,014,969 and the stock's 52-week low/high is $0.006/$0.0425.

The QualityStocks Company Corner

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a data-based financial technology company, recently closed the acquisition of LD Micro, a leading data portal serving the small and micro-cap space. The deal, worth 1,600,000 shares of common stock and $4 million in cash, will make LD Micro a wholly-owned subsidiary of SRAX while maintaining founder Christopher Lahiji as president and appointing him to SRAX’s board of directors.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $2.82, up 2.5231%, on 112,094 volume with 421 trades. The average volume for the last 3 months is 134,996 and the stock's 52-week low/high is $1.04999995/$3.35739994.

Recent News

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of in-process, quality-assurance software for the commercial 3D-printing industry, has been awarded a contract by a leading global energy technology provider. The contract, which was finalized after a successful Rapid Test and Evaluation (“RTE”) program, calls for beginning production deployment of PrintRite3D(R) in-process quality assurance software. To view the full press release, visit http://nnw.fm/oOwHD

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Tuesday's trading session at $2.37, up 3.4934%, on 2,899,674 volume with 10,150 trades. The average volume for the last 3 months is 1,355,231 and the stock's 52-week low/high is $1.95000004/$11.6999998.

Recent News

Kaival Brands Innovations Group Inc. (OTCQB: KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (OTCQB: KAVL).

NetworkNewsWire Editorial Coverage: Approximately 1,300 people die every day as a result of smoking, and more than 16 million Americans are living with a disease caused by smoking. These alarming numbers aren’t going unnoticed, and companies with expertise in the space are seizing the opportunity to provide solutions designed to help smokers kick the habit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), has just acquired a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products; the company is also creating a subsidiary that will own the patent and develop all related products. Also today, NetworkNewsWire released a report on the company detailing how KAVL on Monday announced its entry into a Patent Contribution Agreement (the “Agreement”), under which it will acquire exclusive rights to an international patent portfolio concerning full customization of certain isomeric properties of synthetic nicotine. In addition, the company announced the formation of a new wholly owned subsidiary, Kaival Labs Inc., a Delaware corporation that will own and develop the patent. 

Kaival Brands Innovations Group Inc. (OTCQB: KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (OTCQB: KAVL), closed Tuesday's trading session at $0.365, up 18.6992%, on 156,995 volume with 50 trades. The average volume for the last 3 months is 182,650 and the stock's 52-week low/high is $0.006/$1.09000003.

Recent News

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B)

The QualityStocks Daily Newsletter would like to spotlight Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B).

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) was featured today in a publication from MiningNewsWire. Alaska’s Pebble Mine contains about 1.3% of all the copper metal that has ever been produced or discovered in the world over the last 10,000 years. The mine also contains roughly 1.8% of all the precious gold metal ever produced and is also the largest rhenium deposit in the world. Rhenium is considered to be a rare element and is used in jet engines, high octane fuels and other military applications. Because this rhenium deposit is domestically produced in the U.S., the military considers it to be vital to the long term security of the country.

Bullfrog Gold Corp. (the “Company”) (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation engaged in the acquisition, exploration and development of gold and silver properties in the United States. The Company controls strategic lands with established 43-101 compliant resources in one of the most exciting gold exploration areas in the United States. The Bullfrog Gold Project (“Project”) includes a lease/option on much of the lands where Barrick Bullfrog Inc., a subsidiary of Barrick Gold Corp., produced more than 2.3 million ounces of gold and 2.49 million ounces of silver from 1989 to 1999. The Project is located within the prolific Walker Trend about 125 miles northwest of Las Vegas, Nevada.

Project Highlights

  • The Company initially acquired 79 unpatented claims and two patents in mid-2011 and has since staked, leased, optioned, or purchased lands that now total 5,250 acres. Via a 2015 lease/option with Barrick, the Project includes the northern one-third of the Bullfrog deposit where most of the current resources in the Bullfrog mine area occur, along with their interest in the Montgomery-Shoshone deposit which gave the Company 100% control.
  • In mid-2017, a NI 43-101-compliant report by independent mining consultancy Tetra Tech Inc. estimated measured and indicated (“M&I”) resources of 624,000 ounces of gold and 1.73 million ounces of silver at average grades of 0.70 g/t and 1.93 g/t, respectively. The expansion plans of these two pits were based on a $1200 gold price, use of heap leach processing, and also included 110,000 ounces of inferred gold resources averaging 1.20 g/t. Barrick used conventional milling to process an average gold grade of 3 g/t.
  • The established resources and exploration potential of the Project are strongly supported by a large data base obtained from Barrick, including detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.

Gold Rush in the Bullfrog Territory

The area around Beatty, Nevada has now attracted AngloGold Ashanti, Kinross Gold, Corvus Gold, Coeur Mining as well as the Company and Waterton. In this regard, Northern Empire Resources Corp’s property located a few miles east of the Project was acquired by Coeur Mining in October 2018 for C$117 million, implying a valuation of C$134/oz of inferred resources. As of today, the Company is trading at a significant discount to the valuation at which Northern Empire was purchased (http://nnw.fm/9NaaN), thereby highlighting the Company’s value proposition for investors.

Bullfrog Gold Corp. is focused on enhancing shareholder returns by concurrently advancing Project development and performing exploration drilling programs on several targets identified by the Company.

Secured Financing for 2020 Operations

Bullfrog Gold Corp. raised C$2 million in January 2020 through a private placement of shares priced at C$0.13/share plus a one-half warrant exercisable within two years at C$0.20 on a full warrant basis. The raise was carried out primarily to fund a drill program that started on May 1 (http://nnw.fm/6nZ0m), and was completed on June 6, 2020. Results from drilling 12,520 feet in 25 holes will be released in the coming weeks. The Company subsequently intends to conduct a preliminary financial analysis and complete further drill programs to advance the Project and add value. The financing was subscribed by several influential shareholders, including a former director of Northern Empire, who handled the sale of the company to Coeur Mining, and Eros Resources, the management of which has been involved with several high-profile mining projects and sales in the past.

Gold Prices estimated to average $1,800/oz in 2021

Gold prices have been on a remarkable run in 2020, rising by $245/oz to $1,760 prior to peaking in early May. Global central banks carried out 144 interest rate cuts thus far in 2020, reducing their rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the COVID-19 pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures prompted Credit Suisse to recently hike their gold price forecasts for the full year to $1,701/oz (from $1,570 previously), while the outlook for 2021 has been raised to $1,800/oz (versus $1,600 previously) (http://nnw.fm/Iqg0X).

Management Team

David Beling, CEO, President and Director
David Beling is a Registered Professional Mining Engineer with 55 years of diverse experience in areas such as engineering, development, permitting, construction, financing and management of mines and plants and the building and growth of several corporations. His initial employment included 14 years with Phelps Dodge, Union Oil, Fluor, United Technologies, and Westinghouse, followed by 41 years of senior management and consulting with 25+ U.S. and Canadian mining companies. In 2006-2007, he spearheaded an IPO, successfully drove equity raises totaling C$112 million and grew that Company’s market capitalization to $460 million. Beling has served on 14 boards since 1981, including three mining companies distinguished by the TSX Venture Exchange as top-10 performers.

Alan Lindsay, Chairman of the Board
Alan Lindsay is an entrepreneur and businessman who has founded seven companies within the mining and pharmaceutical industries, including Anatolia Minerals Development Ltd., Uranium Energy Corp., Oroperu Mineral, Strategic American Oil and AZCO Mining. Lindsay also developed the strategic vision for the 2011 acquisition and placement of the Project from NPX Metals into Bullfrog Gold Corp.

Kjeld Thygesen, Director
Kjeld is a graduate of the University of Natal in South Africa and has 48 years of experience as a resource analyst and fund manager. In 1972, he joined James Capel and Co. in London as part of its highly rated gold and mining research team before subsequently becoming manager of N. M. Rothschild & Sons’ commodities and Natural Resources Department in 1979. In 1987, he became an executive director of N. M. Rothschild International Asset Management Ltd., before co-founding Lion Resource Management Ltd., a specialist investment manager in the mining and natural resources sector, in 1989. Thygesen has been a director of Ivanhoe Mines Ltd. since 2001 and served as investment director for Resources Investment Trust PLC from 2002 to 2006.

Tyler Minnick, CFO and Director of Administration & Finance
A registered member of the Colorado Society of Certified Public Accountants with over 24 years of experience within the fields of accounting, auditing, and administrative services. Minnick has been engaged with the Company since mid-2011 and previously worked in the finance department of MDC Holdings/Richmond American Homes, one of the largest residential construction companies in the United States.

Bullfrog Gold Corp. (OTCQB: BFGC), closed Tuesday's trading session at $0.22, up 4.1469%, on 315,755 volume with 54 trades. The average volume for the last 3 months is 356,896 and the stock's 52-week low/high is $0.047449998/$0.27000001.

Recent News

Sanwire Corp. (SNWR)

The QualityStocks Daily Newsletter would like to spotlight Sanwire Corp. (SNWR).

Sanwire Corp. (OTC: SNWR) and its wholly owned subsidiary Intercept Music Inc. have been spotlighted on QualityStocks as a company to watch. Sanwire is a diversified company focusing on technologies related to the entertainment industry. Sanwire has selected InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private and public entities, to lead its corporate communications, and QualityStocks is one of IBN's brands that disseminates featured articles and corporate communications. To view the full press release, visit: https://nnw.fm/Uy11R

Sanwire Corp. (SNWR) is a diversified company currently focused on technologies for the music industry. The company specializes in locating unique opportunities in fragmented markets and implementing its aggregated technologies to consolidate distinct services into unified platforms of delivery. Sanwire is currently focusing these efforts on advanced entertainment technologies.

Founded in 1997 and based out of Las Vegas, Nevada, Sanwire has operated and sold several subsidiaries as it has worked in various industry segments, including Sanwire Software Inc., Bullmoose Mines Ltd. and Squeeze Report Inc. Currently, there are two new holdings that were added to the company’s portfolio through two recent acquisitions, including Intercept Music Inc. in March 2020 and the Art is War Record Label in June 2020.

Intercept Music Inc. – Artist-Focused Services

Intercept Music Inc. is an entertainment technology company offering a unique suite of artist-focused services that are specifically designed to meet the needs of recording artists. Intercept’s proprietary online platform is dedicated to helping millions of global independent artists effectively promote their music and distribute it worldwide to hundreds of digital stores and every major streaming platform, including Spotify, Apple Music, Amazon Music, Pandora and Google Music.

With Intercept Music, recording artists have all the tools needed to market, promote and sell their music online and through social media. Comprehensive reporting allows artists to track the fan response to their releases, all the way down to individual music tracks.

There are three foundations of Intercept Music’s product offering:

  • Its music distribution platform that is well augmented via the company’s partnership with InGrooves, a wholly owned subsidiary of Universal Music, which is arguably one of the largest music companies in the world.
  • Its social media system, which is tailored to work the way artists use social media to promote their music and engage with their fans. The scheduling system integrates artists’ profiles across multiple social networking sites (Facebook, Twitter, Instagram and YouTube) to facilitate new audience sampling, fan development and the ability for music to be previewed and purchased.
  • The third is represented by the team of developers that brings a unique combination of deep technical expertise (in products like Skype), a team of well-accomplished executives and what the company calls Brand Ambassadors – senior reps from multiple genres who have helped artists earn over 100 Grammys.

Intercept Music is the confluence of technology and this music expertise.

The company currently markets three plans to its clients, with each offering different distribution and royalty options, as well as various marketing and reporting options. The plans are described below:

  • Intercept Distro is a basic plan for self-service music distribution with royalty collection. Artists keep 100% of the royalties while receiving unlimited releases and full analytics with reporting.
  • Intercept Artist includes all of the benefits of the basic Distro plan with added emphasis on social marketing and distribution for emerging artists. With this plan, artists receive scheduled and ad-hoc posting, social media reporting, reusable content libraries and access to other valuable features.
  • Intercept PLUS is available by invite only and is for established artists looking for a complete suite of marketing, distribution and monetization services. The PLUS plan includes everything available through the Distro and Artist plans, as well as offering a dedicated service representative, a branded online store, on-demand merchandise, additional marketing, YouTube monetization and other pro features.

Intercept PLUS is the flagship plan. Artists of this caliber often do $3-$10k/month in merchandise sales alone, at 50%+ profit. Intercept is responsible for marketing to the fan base through its social media system and shares in the profits generated. The stores are managed by intercept so both top-line revenues and bottom-line profits flow through Intercept.

Intercept Music has partnered with Ingrooves Music Group, the largest online music distribution company in the world, for worldwide distribution to streaming services and leading stores. Completing more than 50 billion transactions weekly across over 150 countries, Ingrooves supplies music to leading streaming music platforms and lists some of the world’s largest and most reputable music labels among its clients. The partnership allows Intercept Music and its clients to reach a much wider audience and start earning revenue as soon as possible by leveraging Ingrooves’ quality control systems and direct relationships with leading music streaming services.

Physical Distribution Options for Intercept Music Clients

In a press release on June 25, 2020, Intercept Music announced that it would be offering artists physical distribution through major retailers such as Amazon, FYE and Walmart (http://nnw.fm/NSrbE). The physical distribution will consist of CDs and vinyl and will serve as a supplement to the online streaming platform access provided by the company to represented artists.

“In the current climate, artists can’t play shows or otherwise engage in public at all, so they’re focusing on all other opportunities to bring in revenue,” Intercept Music President Tod Turner stated in a news release. “Our only priority is to help artists monetize music in every way, and with physical distribution added to the mix, we’re leaving no stone unturned in helping artists to earn money from their creative output.”

Creation of Preferred Stock

On June 29, 2020, Sanwire CEO Christopher Whitcomb announced that the company would be filing certificates of designation with the Nevada Secretary of State for its Series A, B and C preferred stock (http://nnw.fm/svrQt).

Speaking about this designation in a news release, Whitcomb stated, “Our paramount goal is to maintain a balanced approach between future investments and shareholder value while minimizing shareholder dilution. The effective utilization of preferred stock ensures our company can grow with the least amount of shareholder dilution.”

Sanwire is leveraging a multi-dimensional strategy that includes additional acquisitions, attracting investors and enhancing the current balance sheet while minimizing dilution for shareholders. A primary goal of these efforts is to support Intercept’s ongoing operations.

Financial Highlights

For the fiscal quarter ended June 30, 2020, Sanwire announced significant revenue growth related to the acquisitions of Intercept Music and Art is War Records. Since acquiring Intercept Music in March and Art is War Records in June, Sanwire’s revenue has increased by approximately 300% (http://nnw.fm/j0S0j). Sanwire attributes the increase in revenue to Intercept Music’s customer acquisition and the release of its PLUS plan.

For the third quarter, revenue is expected to continue an upward climb, owing largely to physical distribution plans and a rising number of PLUS subscribers. The company’s acquisition of Art is War Records is also expected to fuel this growth.

Management

Christopher M. Whitcomb is the current CEO of Sanwire Corp. and Intercept Music Inc. He is a CPA in the state of California, holding bachelor’s degrees in accounting, corporate finance and business management with a focus on real estate. A seasoned executive, his business ventures are always strongly focused on the development and financing of companies.

Whitcomb worked alongside Ralph Tashjian at SMC Entertainment Inc. and Digital Music Universe. They are currently working together again following Sanwire’s acquisition of Intercept Music, which was founded by Tashjian.

Sanwire Corp. (SNWR), closed Tuesday's trading session at $0.012, even for the day, on 56,434 volume with 10 trades. The average volume for the last 3 months is 666,212 and the stock's 52-week low/high is $0.002499999/$0.100000001.

Recent News

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth Corp. (NASDAQ: DRIO) was featured today in a publication from BioMedWire, examining how three scientists from Johns Hopkins; a biomedical engineer, a pharmacologist and a biophysicist, have come together to build a device that can detect if an individual has SARS-CoV-2 antibodies, which is the virus that causes COVID-19. Antibodies are small proteins produced by the immune system to help your body counteract a viral encounter and provide the immunity to fight it off if future infections occur.

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Tuesday's trading session at $16.60, off by 5.6818%, on 86,803 volume with 724 trades. The average volume for the last 3 months is 261,037 and the stock's 52-week low/high is $3.01999998/$22.4899005.

Recent News

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE) was featured today in a publication from Green Car Stocks, examining how it’s becoming increasingly difficult to bury our heads in the sand in regard to climate change. The earth is hurtling towards a ‘hothouse’ state not seen in 50 million years and a lot of the blame lies at the feet of humanity. Perhaps the most obvious sign of climate change is that it’s getting hotter and according to scientists, the next three years might be even hotter than normal. No state has experienced the heat as much as California; five of the largest wildfires in state history have been ignited in recent weeks, and residents have become accustomed to rolling blackouts due to heat waves.

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Tuesday's trading session at $6.88, off by 0.864553%, on 492,913 volume with 2,776 trades. The average volume for the last 3 months is 1,490,790 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has expanded its Scientific Advisory Board by welcoming new member Dr. Patrick Wen, M.D., a leading neurology and neuro-oncology expert (https://ibn.fm/VJ6e9). Dr. Wen joins current Board members, Dr. Waldemar Priebe, Ph.D., and Dr. Sigmund Hsu, M.D., both of whom were involved in the Phase 1 trial of Berubicin, CNS Pharmaceuticals’ lead drug candidate.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Tuesday's trading session at $1.78, off by 1.1111%, on 19,020 volume with 94 trades. The average volume for the last 3 months is 105,604 and the stock's 52-week low/high is $1.25820004/$5.68989992.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, is set to play a key role as the integration of AI technology within cancer care continues to improve the accuracy and speed of diagnosis, aid clinical decision-making and lead to better health outcomes. 

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Tuesday's trading session at $0.8277, off by 0.180897%, on 387,396 volume with 833 trades. The average volume for the last 3 months is 1,479,101 and the stock's 52-week low/high is $0.810000002/$6.00099992.

Recent News

Pac Roots Cannabis Corp. (CSE: PACR)

The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).

Pac Roots Cannabis Corp. (CSE: PACR) was featured today in the 420 with CNW by CannabisNewsWire. According to a survey that was released earlier this week (on Tuesday), new marijuana users make up about a quarter of all legal Canadian cannabis consumers. However, many seem to be shying away from cannabis-infused products, which were created for the sole purpose of drawing in more consumers into the market.

Pac Roots Cannabis Corp. (CSE: PACR) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.

The company began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, it is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months, including its formation of an outdoor premium hemp joint venture with partner Rock Creek Farms in British Columbia, Canada, and its agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.

Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.

High-End Selectively Bred Genetics

Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.

The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.

Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.

A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.

The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.

Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.

Partnership with Phenome One

Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.

Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.

Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

Joint Venture with Rock Creek Farms of British Columbia

Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).

Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.

About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.

“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”

Infinite Development Possibilities at Fraser Valley Property in British Columbia

In mid-July 2020, the company initiated a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (http://nnw.fm/xlpw7). Notably, 1088 owns and controls 250 acres of land spread over nine parcels in the Fraser Valley Regional District.

The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

The closing date for the transaction is slated for September 4, 2020, after a 51-day due diligence period. According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.

“This land has no zoning restrictions and is not situated within the agricultural land reserve, which provides for infinite development possibilities,” Elliott added in a July 2020 news release.

Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.

The RAD Americas Genetic Program – Research and Development in Americas Genetic Program

Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.

The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.

Through its RAD Americas Development and Innovation, Pac Roots is focused on:

  • Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
  • Continued stress testing for indoor, high yield, THC and medicinal genetics
  • Continued stress testing for outdoor, high yield, THC and medicinal genetics
  • Exotic, genetic cloning for the luxury, high margin, cannabis flower market
  • Psychoactive/medicinal ratio testing for effect and
  • Unique Cannabinoid and terpene elevation and isolation.

Through its RAD Americas Field Testing System, the company is focused on:

  • Global testing in different microclimates to assess genetic and complete systems for optimal yields
  • Data collection, testing and optimization to prove process for commercial implementation and
  • High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.

Lake Country Cultivation Facility near Kelowna, British Columbia

Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.

Management Team

Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.

Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.

Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.

Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.

Pac Roots Cannabis Corp. (PACR), closed Tuesday's trading session at $0.21, off by 6.67%, on 12,000 volume with 5 trades. The average volume for the last 3 months is 22,758 and the stock's 52-week low/high is $0.11/$0.72.

Recent News

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studio (OTC: MVES), a vertically integrated motion picture production and distribution company, has partnered with two key entities — Digital Talent Studio and Sikey Corp. — in a move to strengthen its social media branding, engagement of influencers, and advertising on key social media platforms. Digital Talent Studio and social media mogul Brian Breach from Sikey Corp. will be involved in social media ad placement strategies aimed at target demographics and engaging social media influencers. To view the full press release, visit http://nnw.fm/WlR3g

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Tuesday's trading session at $0.00955, off by 3.1931%, on 54,364 volume with 6 trades. The average volume for the last 3 months is 213,005 and the stock's 52-week low/high is $0.006099999/$0.039999999.

Recent News

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for electric motors and powertrains, today announced that Julie (McCoy) Wurmlinger, an accomplished engineering leader in the automotive industry, has joined the Exro Board of Directors. According to the update, Wurmlinger brings a global perspective to innovation and product development in the powertrain sector with more than 30 years of industry experience. To view the full press release, visit http://nnw.fm/RlFea

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Tuesday's trading session at $1.25, up 23.7624%, on 633,260 volume with 495 trades. The average volume for the last 3 months is 354,423 and the stock's 52-week low/high is $0.150000005/$1.27999997.

Recent News

ISW Holdings (ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings (ISWH).

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced that its recently launched telehealth subsidiary, Telecare Home Health LLC, has received its license under Chapter 142 of the Texas Health and Safety Code to operate in the state of Texas. In addition, the process of review toward accreditation is now underway for Telecare. To view the full press release, visit: https://ccw.fm/69JhB

ISW Holdings (ISWH) (“ISW Holdings”) is a brand management portfolio company with diverse partnerships that focus on growing businesses in multiple sectors, including crypto mining, renewable energy, home health care for the chronically ill, wellness and restoration, and the adult beverage industry, as well as early-stage operations in supply chain and logistics management. ISW Holdings operates as the nexus between its partnerships and their essential services for end users.

Mission
The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources, and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.

The Revolution
Positioned to create industry leaders, the company’s process entails strategic development and aggressive early growth of its partner brands to establish them as profitable and viable. ISW Holdings’ method is to nurture emerging partner brands through the essential stages of market development (from conceptualization to distribution) in sectors relevant to today’s marketplace. In addition, the company has a holistic approach to business development, with every strategy being delivered person-to-person from developers to end users.

The Challenge
The company’s goal is to turn its target audience into loyal consumers by ensuring transparency and a clear understanding of its products and services, thus creating visibility, credibility, and trust.

ISW Holdings’ Innovative Approach
ISW Holdings has diversified positions in its partnerships across technology, health care, wellness, renewable energy, and the adult beverage sectors. The company seek to provide industry leading modern solutions to its clients and sound business practices to its partners. This is accomplished through an early growth platform that cultivates its partnerships with the necessary resources and expertise to expand exponentially.

ISW Holdings’ Opportunity
The company’s opportunity is considerable. In the ever-changing high demand global marketplace, the need for timely innovation is critical. ISW Holdings’ portfolio brand management and creative thinking has allowed the company to develop and deploy enterprises that meet the needs of 21st century consumers. Through a fully vetted system of scalability, it is able to meet consumer demands with turn-key solutions.

Portfolio of Partnerships and Businesses
ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. With partnerships that incorporate a depth of experience and industry insight, ISW Holdings has established itself as a portfolio company in technology, home health care, and wellness, with a focus on reshaping industry benchmarks.

Bit5ive

ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. As an official distribution partner of Bitmain (the industry’s leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean), Bit5ive is quickly becoming one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm sectors of the market.
Valued at $293.66 million in 2019, the bitcoin technology market is expected to reach $477 million by 2025, according to Mordor Intelligence. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.

Proceso, LLC

With a growing awareness of the importance of renewable energy worldwide, ISW Holdings has partnered with Proceso, LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining – two fields with a typically high energy demand.

Because crypto mining companies mostly operate outside of the United States with higher asset security risks, Proceso will assist these entities in securing their investments by providing a local source of power and infrastructure development. This is aimed at helping to reduce power consumption while creating secure crypto mining data centers in the U.S. For the gaming industry, Proceso is ready to tackle one of its biggest problems, latency, by building next-level infrastructure in key locations.

PHH – Home Health

PHH Paradigm Home Health answers the growing need for homecare services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care. PHH aims to be at the forefront of this change by offering quality care services infused with new emerging technologies.

ISW Holdings’ home health division is currently developing a pilot for on-demand health care, which consists of a dedicated, stable platform for different medical services. The platform will offer greater freedom of choice and transparency by allowing users to find outpatient clinics in their vicinities, compare costs, and pick the most suitable choices. PHH is also developing specialized technology and tools to support health care services outside of the bounds of specialized facilities by focusing on homecare facilities. This can not only shift the burden from hospitals and clinics, but also streamline specific parts of the health care process to enhance service and product distribution.

VOLUM

ISW Holdings’ logistics and supply chain management division was designed with the core goal of increasing supply chain efficiency as one of the key aspects of successfully growing any business. The VOLUM project’s focus is on identifying and then implementing advanced supply chain management strategies and methods that will enable ISW Holdings’ partner companies to scale and grow exponentially. To achieve this goal, the company develops and offers reliable systems and solutions that create innovative technologies and unmanned system operations for overall higher cost-effectiveness.

In the wellness sector, ISW Holdings has opted for a two-pronged approach to create effective, technologically advanced products, as well as developing innovative ways to educate customers about these products. To this end, ISW Holdings has partnered with BioPulse to achieve state-of-the-art research and development and production capabilities, as well as a direct route to market. The company plans to design and launch up to five unique brands in the wellness and restoration sector in 2020.

ISW Holdings is committed to developing product and service innovation in the consumer spirits and adult beverage industry, which faces increasingly strict regulations but growing demand. The company has been a key innovator in the industry for 25 years, having grown successful luxury brands such as Besado Tequila and others. By leveraging its expertise, ISW Holdings can help companies in the adult beverage industry increase production, streamline their supply chains, implement better processes, innovate their marketing strategies, expand into new areas, and build sustainable relationships with partners and customers.

Management Team

Terry Williams, Chief Executive Officer and Director
Terry Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance, and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, Williams amassed considerable corporate experience at United Parcel Service, where he took several logistical roles, including controller, where he managed more than 2,000 employees and a budget of more than $10 billion.

Williams also serves as president of Airwave Transportation and logistics and chief financial officer of AVI Insurance Caribbean, and he has worked in over 37 domestic and international airports. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce, Chairman
Alonzo Pierce is chairman of ISW Holdings and brings a wealth of business development and wealth management experience to the ISW team. He has spent the past 20 years building recognizable brands in multiple industry sectors. He has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands, including selling the world’s only black vodka. He served as regional director for Sapphire Brands, covering the Southwest and Southeast regions. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown, Secretary, Treasurer, Director
Kristina Mahoney-Brown is secretary and treasurer as well as director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings (ISWH), closed Tuesday's trading session at $0.1174, up 0.085251%, on 63,385 volume with 16 trades. The average volume for the last 3 months is 141,296 and the stock's 52-week low/high is $0.07/$3.00.

Recent News

Cannabis Global Inc. (CBGL)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (CBGL).

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has announced its Hemp You Can Feel(TM) Challenge. The challenge involves CBGL offering free samples of its new honeybee-powered water-soluble hemp extract sweetener line, which is slated for release in the coming weeks. The free samples, available while supplies last, can be requested by filling out an online request form.

Cannabis Global Inc. (CBGL) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June 2019 and announced its intent to enter the cannabis sector. In August 2020, it changed its corporate identity from MCTC Holdings Inc. to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, CBGL plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

CBGL is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. CBGL believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

CBGL leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, CBGL has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

CBGL has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

CBGL collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market CBGL’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by CBGL. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

CBGL CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

CBGL founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at Cannabis Global.

Cannabis Global, Inc. (CBGL), closed Tuesday's trading session at $0.0909, off by 9.1908%, on 200,881 volume with 23 trades. The stock's 52-week low/high is $0.05/$3.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.